## INCY: Incyte Corporation - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 2.0% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($95.90)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Who Owns Incyte Corporation? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20260102T200757 | Bullish | Relevance: 100%
- This article analyzes the major shareholders and recent insider trading activity for Incyte Corporation (NASDAQ: INCY). It details the largest institutional holders, their recent trading actions, and highlights significant hedge fund adjustments. The report concludes that Incyte's ownership structure is stable, supported by high-conviction funds, and insider activity, while cautious, does not suggest a material change in the long-term outlook.

**2. (INCY) as a Liquidity Pulse for Institutional Tactics**
- Source: Stock Traders Daily | 20260101T200823 | Bullish | Relevance: 100%
- This article, published by Stock Traders Daily, analyzes Incyte Corporation (NASDAQ: INCY) using AI models to provide institutional trading strategies. It highlights a weak near-term sentiment but strong long-term outlook, offering specific entry, target, and stop-loss points for position, momentum, and risk-hedging strategies. The analysis presents multi-timeframe signal strengths and key support/resistance levels.

**3. VIRGINIA RETIREMENT SYSTEMS ET Al Has $65.16 Million Holdings in Incyte Corporation $INCY**
- Source: MarketBeat | 20251231T115750 | Somewhat-Bullish | Relevance: 100%
- Virginia Retirement Systems increased its stake in Incyte Corporation by 4.5% to 768,325 shares, valued at $65.16 million, as institutional ownership of the stock reached 96.97%. While analysts have a "Hold" consensus with an average target of $99.79, Q3 earnings surpassed expectations by a significant margin. However, insiders have recently sold approximately 88,318 shares worth about $8.7 million.

**4. Should First Trust Growth Strength ETF (FTGS) Be on Your Investing Radar?**
- Source: sharewise.com | 20251231T060912 | Neutral | Relevance: 58%
- The First Trust Growth Strength ETF ($FTGS) provides broad exposure to the Large Cap Growth segment of the US equity market, with over $1.27 billion in assets. While offering diversification and holding companies like Eli Lilly ($LLY), its 0.6% expense ratio is higher than some alternatives. The ETF has gained 14.03% year-to-date and 12.91% over the last year as of December 30, 2025.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Morgan Stanley | $92 | $86 | +7% |
| 2025-12-08 | Wells Fargo | $116 | $97 | +20% |
| 2025-12-08 | Mizuho | $121 | $90 | +34% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Morgan Stanley | main | Equal-Weight |
| 2025-12-08 | Wells Fargo | main | Overweight |
| 2025-12-08 | Mizuho | up | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 18 ($30.49M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 59.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Baker Bros. Advisors: 15.7% (0.0%)
- Vanguard Group Inc: 10.2% (-0.9%)
- Blackrock Inc.: 9.1% (-0.3%)
- Dodge & Cox Inc.: 7.1% (-4.5%)
- State Street Corpora: 4.9% (-2.0%)

### Key Risks

1. Heavy insider selling: $30M sold (18 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 3 raises (avg +20%) could attract flows.
- Momentum building: MRS_10 improving +2.4% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 0.13 indicates undervaluation relative to growth. Forward P/E 13.2x attractive for 14% earnings growth. Quality metrics strong (ROE 30%, ROA 14%, margin 25%). Balance sheet: strong liquidity (3.2x), low leverage (D/E 0.36). Analyst sentiment positive (3 raises, avg +20%). Insider selling cluster ($30.5M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.9B |
| Beta | 0.81 |
| 52W Range | $53.56 - $109.28 |
| Short Interest | 7.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.13 |
| Forward P/E | 13.2 |
| Current P/E | 15.1 |
| YoY Growth | 13.7% |
| EPS Direction | RISING |

### Technicals

MRS_10 strengthening from -0.4% to 2.0% (+2.4% in 5 days), confirming momentum buildup. Below STRENGTH zone by 1.0pp (needs >3.0% for momentum thesis). MRS_5 at 2.4% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56. OFD pattern: +FTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 2.03% (CS: 75) | Neutral |
| RSI_14 | 55.5 | Neutral |
| MACD Histogram | 0.11 | Bullish |
| vs SMA20 | 1.027x | Above |
| vs SMA50 | 1.015x | Above |
| vs SMA200 | 1.281x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $101.42
- **Stop Loss:** $95.90 (5.4% risk)
- **Target:** $106.94 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 260
- **Position Value:** $26,369.20
- **Portfolio %:** 26.37%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-09 (Est: $1.89)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.64 | $2.26 | +38.0% |
| 2025Q2 | $1.47 | $1.57 | +6.6% |
| 2025Q1 | $1.03 | $1.16 | +12.3% |
| 2024Q4 | $1.55 | $1.43 | -8.0% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*